Search

everythinglearnresearchcommunity

for

Search:↓

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Different γδ T cell types have unique roles in causing alopecia areata.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Certain RNAs may help diagnose alopecia areata by affecting keratin genes.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Vitiligo and alopecia areata may have similar causes despite their differences.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

Vitamin D might help treat alopecia areata.

Targeted immune modulation can help achieve stable remission in alopecia areata.

New treatments like JAK inhibitors offer hope for hair regrowth in severe alopecia areata.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Adalimumab may cause severe hair loss in some patients.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Some people with chronic hair loss may have thyroid autoimmunity.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

People with Alopecia Areata have lower vitamin D levels.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Alopecia areata causes patchy hair loss and is often treated with corticosteroids.

Combining Ayurvedic and modern treatments can effectively manage hair loss.

JAK inhibitors may help treat alopecia areata in children, but their safety needs careful evaluation.

Alopecia areata is an autoimmune disease causing hair loss, linked to immune and gut issues, needing more research for better treatments.

Janus kinase inhibitors show promise for treating alopecia areata in children.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.